We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

ISS a good thing to sell

1 March 2010 By Robert Cyran

The analytics business spun out by Morgan Stanley is paying $1.6 bln for the risk management and corporate advisory firm. The price looks a bit value destructive. A bigger question may be what to do with RiskMetrics proxy service ISS, and potential conflicts of interest.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)